Epidemiological aspects of heart diseases (Review)

Experimental and Therapeutic Medicine

Volumn 12, Issue 3, 2016, Pages 1645-1650

  Shi, Aimin ^a   Tao, Ziqi ^b   Wei, Peng ^b   Zhao, Jing ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Cardiovascular diseases; Coronary heart disease; Rheumatic heart disease

Indexed keywords

ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALCOHOL CONSUMPTION; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; FOOD INTAKE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MALNUTRITION; MEDICAL SOCIETY; MEDITERRANEAN DIET; MORTALITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SMOKING;

EID: 84980329506     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3541     Document Type: Review

References (65)

1. Adeyi O, Smith O and Robles S: Public policy and the challenge of chronic noncommunicable diseases. The World Bank, Washington, DC, 2007.
2. WHO Expert Committee on Problems Related To Alcohol Consumption: Second Report. World Health Organization Technical Report Series. World Health Organization, Geneva, pp 1-65, 2007. Mongolian STEPS Survey on the Prevalence of Noncommunicable Disease Risk Factors 2006. World Health Organization Western Pacific Region, Manila, Philippines, 2007.
3. World Health Statistics 2009. WHOSIS (World Health Organization Statistical Information System). World Health Organization, Geneva, pp1-149, 2009.
4. The Current Evidence For The Burden Of Group A Streptococcal Diseases. Discussion Papers On Child Health. World Health Organization, Department of Child and Adolescent Health and Development, Geneva, pp 1-60, 2005.
5. Beaglehole R and Bonita R: Global public health: a scorecard. Lancet 372: 1988-1996, 2008.
6. Fuster V and Kelly BB (eds): Epidemiology of cardiovascular disease. In: Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. National Academies Press, Washington, DC, 2015.
7. Leeder S, Raymond S, Greenberg H, Liu H and Esson K: A Race Against Time: The Challenge Of Cardiovascular Disease In Developing Economics. Columbia University, New York, NY, pp 1-54, 2004.
8. Shopland DR: Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 103 (Suppl 8): 131-142, 1995.
9. Clarke R, Emberson J, Fletcher A, Breeze E, Marmot M and Shipley MJ: Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ 339: b3513, 2009.
10. Shafey O, Eriksen M, Ross H and Mackay J: The tobacco atlas. 3rd edition. American Cancer Society, Atlanta, 2009.
11. WHO: Childhood overweight and obesity. http://www.who.int/dietphysicalactivity/childhood/en/WHO. Accessed December 12, 2008. The Global Burden Of Disease: 2004 Update. World Health Organization Geneva, 2008. Who Report On The Global Tobacco Epidemic, 2008: The Mpower Package. World Health Organization, Geneva, 2008.
12. Reddy SP, Panday S, Swart D, Jinabhai CC, Amosun SL, James S, Monyeki KD, Stevens G, Morejele N, Kambaran NS, et al: Umthenthe uhlaba usamila: the South African Youth Risk Behavior Survey 2002. South African Medical Research Council, Cape Town, 2003.
13. Misra A and Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 93 (Suppl 1): S9-S30, 2008.
14. Bhardwaj S, Misra A, Khurana L, Gulati S, Shah P and Vikram NK: Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation. Asia Pac J Clin Nutr 17 (Suppl 1): 172-175, 2008.
15. Hu FB: Globalization of food patterns and cardiovascular disease risk. Circulation 118: 1913-1914, 2008.
16. Khan M and Mensah G: Changing practices to improve dietary outcomes and reduce cardiovascular risk: a food company’s perspective. Background Paper Commissioned by the Committee, Purchase, NY, 2009.
17. Barker DJ, Martyn CN, Osmond C, Hales CN and Fall CH: Growth in utero and serum cholesterol concentrations in adult life. BMJ 307: 1524-1527, 1993.
18. Celermajer DS and Ayer JG: Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart 92: 1701-1706, 2006.
19. Freedman DS, Khan LK, Dietz WH, Srinivasan SR and Berenson GS: Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. Pediatrics 108: 712-718, 2001.
20. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, Herderick EE and Cornhill JF: Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281: 727-735, 1999.
21. Smith GD, McCarron P, Okasha M and McEwen J: Social circumstances in childhood and cardiovascular disease mortality: prospective observational study of Glasgow University students. J Epidemiol Community Health 55: 340-341, 2001.
22. Galobardes B, Smith GD and Lynch JW: Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann Epidemiol 16: 91-104, 2006.
23. Myint PK, Luben RN, Wareham NJ, Bingham SA and Khaw KT: Combined effect of health behaviours and risk of first ever stroke in 20,040 men and women over 11 years’ follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): Prospective population study. BMJ 338: b349, 2009.
24. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE and Rimm EB: Primary prevention of stroke by healthy lifestyle. Circulation 118: 947-954, 2008.
25. He FJ and MacGregor GA: A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 23: 363-384, 2009.
26. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamb J, Al-Hinai A, Keltai M and Yusuf S; INTERHEART Study Investigators: Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 118: 1929-1937, 2008.
27. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y and Patra J: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373: 2223-2233, 2009.
28. Mukamal KJ, Chiuve SE, Rimm EB, Mukamal KJ, Chiuve SE and Rimm EB: Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 166: 2145-2150, 2006.
29. Diet, Nutrition And The Prevention Of Chronic Diseases: Report Of A Joint Who/Fao Expert Consultation. Who Technical Report Series. World Health Organization, Geneva, 2003.
30. Sassi F, Cecchini M, Lauer J and Chisholm D: Improving Lifestyles, Tackling Obesity: The Health And Economic Impact Of Prevention Strategies. Organisation for Economic Co-operation and Development, Paris, 2009.
31. Caballero B: A nutrition paradox-underweight and obesity in developing countries. N Engl J Med 352: 1514-1516, 2005.
32. Wang L, Qi X, Chen C, Ma J, Li L, Rao K, Kong L, Ma G, Xiang H, Pu J, et al (eds). Survey and report on the status of nutrition and health of the Chinese people: a comprehensive report for 2002. People’s Medical Publishing House, Beijing, 2005.
33. Office of the National Statistics, Report, 2003.
34. Lawes CMM, Vander Hoorn S and Rodgers A; International Society of Hypertension: Global burden of blood-pressure-related disease, 2001. Lancet 371: 1513-1518, 2008.
35. He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, Chen JC, Chen CS, Bazzano LA, Reynolds K, et al: Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 374: 1765-1772, 2009.
36. Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC and Koplan JP: Emergence of chronic non-communicable diseases in China. Lancet 372: 1697-1705, 2008.
37. Kannel WB, Dawber TR, Kagan A, Revotskie N and Stokes J II: Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55: 33-50, 1961.
38. Kannel WB, Castelli WP, Gordon T and McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74: 1-12, 1971.
39. Gotto AM Jr: Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop lecture. J Am Coll Cardiol 46: 1219-1224, 2005.
40. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP and Frick MH: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85: 37-45, 1992.
41. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W and Gotto AM Jr,; for the AFCAPS/TexCAPS Research Group: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615-1622, 1998.
42. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, et al: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335: 1001-1009, 1996.
43. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH and Packard CJ; West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307, 1995.
44. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al; INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952, 2004.
45. Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJL: Global burden of disease and risk factors. World Bank, Washington, DC, 2006.
46. Booth GL, Kapral MK, Fung K and Tu JV: Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368: 29-36, 2006b.
47. Huxley R, Barzi F and Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332: 73-78, 2006.
48. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespérance F, Mark DB, Sheps DS, Taylor CB and Froelicher ES; American Heart Association Prevention Committee of the Council on Cardiovascular Nursing; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research; American Psychiatric Association: Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118: 1768-1775, 2008.
49. Figueredo VM: The time has come for physicians to take notice: the impact of psychosocial stressors on the heart. Am J Med 122: 704-712, 2009.
50. Brook RD: Cardiovascular effects of air pollution. Clin Sci (Lond) 115: 175-187, 2008.
51. Pope CA III, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D and Godleski JJ: Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109: 71-77, 2004.
52. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, et al; American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group: Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115: 2878-2901, 2007.
53. Gajalakshmi V, Peto R, Kanaka TS and Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 362: 507-515, 2003a.
54. Wong ND: Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 11: 276-289, 2014.
55. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146, 2008.
56. Sliwa K and Mayosi BM: Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 99: 1317-1322, 2013.
57. Mediterranean Diet. American Heart Association, Updated: August 11, 2014.
58. Pearson TA: Recent Advances in Preventive Cardiology and Lifestyle Medicine. Public Policy Approaches to the Prevention of Heart Disease and Stroke. Circulation 124: 2560-2571, 2011.
59. The Victoria Declaration On Heart Health Victoria. Health and Welfare Canada, Victoria, Canada, 1992.
60. The Osaka Declaration: Health, Economics, And Political Action: Stemming The Global Tide Of Cardiovascular Disease. Declaration of the Fourth International Heart Health Conference, Osaka (Japan), May 2001. Health Canada, 2001.
61. Elixhauser A, Yu K, Steiner C and Bierman AS: Most Common reasons for hospitalizations by age groups. In: Hospitalization in the United States, 1997. HCUP Fact Book No. 1. Agency for Healthcare Research and Quality, Rockville, MD, p 13, 2000.
62. Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, Burke GL and Lima JA: Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med 168: 2138-2145, 2008.
63. Nichols M, Townsend N, Scarborough P and Rayner M: Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 35: 2950-2959, 2014.
64. Bhatnagar P, Wickramasinghe K, Williams J, Rayner M and Townsend N: The epidemiology of cardiovascular disease in the UK 2014. Heart 101: 1182-1189, 2015.
65. Vasan Ramachandran S and Peter WF Wilson: Epidemiology and causes of heartfailure. Wolters Kluwer Health Clinical Solutions: 2015.